earnings
AA
NASDAQ · AARD
Aardvark Therapeutics, Inc. Common Stock
Healthcare · Biotechnology
$5.53
Up+$0.38 (+7.38%)
Updated Sep 18, 2026, 5:09 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 271.95M
- P/E ratio
- -5.56
- Dividend yield
- 0.00%
- 52-week range
- $3.35 – $17.94
- Volume
- 258.08K
- Avg. volume
- 188.95K
Price performance
AARD price history
1M range · 20 trading sessions · Daily adjusted prices
AARD closed at $5.53 after 20 trading sessions, down 6.11% for the selected period.
- Last close
- $5.53
- Period change
- -6.11%
- Period low
- $4.92
- Period high
- $7.25
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $5.32 | $5.77 | $5.19 | $5.53 | 258.08K |
| Sep 16, 2026 | $5.04 | $5.29 | $4.93 | $5.15 | 47.91K |
| Sep 15, 2026 | $5.47 | $5.545 | $5.01 | $5.02 | 64.15K |
| Sep 14, 2026 | $4.90 | $5.88 | $4.80 | $5.55 | 216.86K |
| Sep 11, 2026 | $5.11 | $5.54 | $4.975 | $5.13 | 276.57K |
| Sep 10, 2026 | $4.87 | $5.015 | $4.54 | $5.01 | 209.38K |
| Sep 9, 2026 | $5.33 | $5.456 | $4.895 | $4.92 | 109.95K |
| Sep 8, 2026 | $5.33 | $5.71 | $5.10 | $5.33 | 164.75K |
| Sep 4, 2026 | $5.72 | $5.991 | $5.15 | $5.38 | 257.81K |
| Sep 3, 2026 | $5.92 | $6.19 | $5.60 | $5.73 | 89.32K |
| Sep 2, 2026 | $6.05 | $6.225 | $5.795 | $5.95 | 59.41K |
| Sep 1, 2026 | $6.00 | $6.245 | $5.807 | $5.92 | 85.01K |
| Aug 31, 2026 | $5.70 | $6.155 | $5.30 | $6.10 | 125.44K |
| Aug 28, 2026 | $6.47 | $6.47 | $5.62 | $5.79 | 143.1K |
| Aug 27, 2026 | $6.89 | $7.085 | $6.585 | $6.62 | 74.26K |
| Aug 26, 2026 | $7.29 | $7.30 | $6.21 | $6.81 | 111.94K |
| Aug 25, 2026 | $6.94 | $7.31 | $6.49 | $7.25 | 145.2K |
| Aug 24, 2026 | $6.75 | $6.97 | $6.2826 | $6.88 | 83.3K |
| Aug 21, 2026 | $5.91 | $6.90 | $5.80 | $6.82 | 173.69K |
| Aug 20, 2026 | $6.76 | $7.12 | $5.76 | $5.89 | 250.19K |
Latest AARD news
The latest Smart Investors Daily articles mentioning AARD.
Stock researchCompany · Forecast
Loading stock research…